|

Neoantigen Personalized Cancer Vaccine Clinical Trials

1 actively recruiting trial

Also known as: deepGeneAI-001

Pipeline

Phase 1: 1

Top Sponsors

  • Ruijin Hospital1

Indications

  • Personalized Neoantigen Vaccine in Combination With Anti-PD-1 Inhibitors in Standard Therapy-Failed and Adjuvant Therapy1
  • Gastrointestinal Tumors1
  • Cancer1

Other1 trial

Personalized mRNA Cancer Vaccine for Gastrointestinal Solid Tumor Treatment
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.